Leukemia provides the science community with the most crucial research and advances in leukemia and allied diseases.
Free online issue
Volume 22, No 12
December 2008
ISSN: 0887-6924
EISSN: 1476-5551
2007 impact factor 6.924*
6/63 Hematology
13/132 Oncology
Editor-in-Chief:
N Muller-Bérat Killmann
* Journal Citation Reports, Thomson Reuters, 2008
FEATURED ARTICLES
REVIEW
Etiology of common childhood acute lymphoblastic leukemia: the adrenal hypothesis FREEORIGINAL ARTICLE
Blockade of mTOR signaling potentiates the ability of histone deacetylase inhibitor to induce growth arrest and differentiation of acute myelogenous leukemia cellsORIGINAL ARTICLE
The combination of bortezomib, melphalan, dexamethasone and intermittent thalidomide is an effective regimen for relapsed/refractory myeloma and is associated with improvement of abnormal bone metabolism and angiogenesisORIGINAL ARTICLE
Efficacy and safety of dasatinib in imatinib-resistant or -intolerant patients with chronic myeloid leukemia in blast phase FREEORIGINAL ARTICLE
SOCS2: inhibitor of JAK2V617F-mediated signal transduction FREELeukemia News
Spotlights
Leukemia spotlights focus on topical research in the field and contain both reviews and original manuscripts. These fields include Angiogenesis, Imatinib as a Model for Signal Transduction Inhibitors, Signal Transduction Inhibitors, Molecular Targeted Therapy, Chronic Lymphocytic Leukemia, Stem cells and Acute Promyelocytic Leukemia.
Click here to view Recent SpotlightsOther NPG news
New horizons in cancer research
This Nature web focus combines News Features, newly published papers concerning cancer stem cells and tumour angiogenesis, and a comprehensive archive of selected papers reporting important advances in cancer research. See this and more at the New horizons in cancer research website.
-
Research and Reviews
Latest research highlights and reviews from the NPG family of journals
